CytomX Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 7.31 M | $7.53 M | -6.40% | 8.59% |
| BVF INC/IL | 02/14/2025 | 5.23 M | $5.39 M | 0.00% | 6.14% |
| VANGUARD GROUP INC | 02/11/2025 | 5.16 M | $5.32 M | 0.00% | 6.07% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 3.91 M | $4.02 M | 29.21% | 4.59% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 3.22 M | $3.32 M | 25.81% | 3.79% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 3.14 M | $3.23 M | 1.16% | 3.69% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 2.65 M | $2.73 M | 100.00% | 3.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 1.55 M | $1.59 M | 1.52% | 1.82% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/14/2025 | 1.38 M | $1.42 M | 13.95% | 1.62% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 1.35 M | $1.39 M | 32.69% | 1.58% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 1.25 M | $1.29 M | 0.00% | 1.47% |
| BLACKROCK, INC. | 02/07/2025 | 1.24 M | $1.28 M | 6.09% | 1.46% |
| CONGRESS PARK CAPITAL LLC | 01/15/2025 | 964,590 | $993,528 | -20.68% | 1.13% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 815,643 | $840,331 | 1.51% | 0.96% |
| JPMORGAN CHASE & CO | 02/12/2025 | 811,630 | $835,978 | 288,736.30% | 0.95% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 599,850 | $617,846 | -63.52% | 0.70% |
| UBS GROUP AG | 02/14/2025 | 508,556 | $523,812 | 635.60% | 0.60% |
| SEI INVESTMENTS CO | 02/11/2025 | 487,902 | $502,539 | 0.00% | 0.57% |
| ALTIUM CAPITAL MANAGEMENT LP | 02/13/2025 | 467,491 | $481,516 | -48.91% | 0.55% |
| FORMIDABLE ASSET MANAGEMENT, LLC | 02/19/2025 | 382,529 | $394,005 | 55.50% | 0.45% |
| TOROSO INVESTMENTS, LLC | 02/14/2025 | 382,529 | $394,005 | 55.50% | 0.45% |
| 02/10/2025 | 364,306 | $375,235 | 100.00% | 0.43% | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 331,624 | $341,573 | -7.01% | 0.39% |
| CITADEL ADVISORS LLC | 02/14/2025 | 322,311 | $331,980 | 1.64% | 0.38% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 320,767 | $330,390 | -31.96% | 0.38% |
| STATE STREET CORP | 02/14/2025 | 320,043 | $329,644 | 21.39% | 0.38% |
| FMR LLC | 02/13/2025 | 306,783 | $315,986 | 7.91% | 0.36% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 02/10/2025 | 286,480 | $295,074 | 2.10% | 0.34% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 241,980 | $249,239 | 0.00% | 0.28% |
| NORTHERN TRUST CORP | 02/14/2025 | 150,632 | $155,151 | 15.97% | 0.18% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 02/13/2025 | 145,036 | $149,387 | -83.96% | 0.17% |
| HRT FINANCIAL LP | 02/14/2025 | 110,242 | $113,000 | 310.74% | 0.13% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 98,383 | $101,334 | 302.22% | 0.12% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 64,300 | $66,229 | 76.16% | 0.08% |
| FOREFRONT ANALYTICS, LLC | 02/14/2025 | 64,259 | $66,189 | 7.53% | 0.08% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 59,778 | $61,571 | 480.14% | 0.07% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 57,012 | $59,000 | -35.59% | 0.07% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 55,108 | $56,761 | 0.00% | 0.06% |
| COMMONWEALTH EQUITY SERVICES, LLC | 02/10/2025 | 53,243 | $55,000 | -1.84% | 0.06% |
| PRIVATE ADVISOR GROUP, LLC | 02/03/2025 | 44,002 | $45,322 | -15.67% | 0.05% |
| 02/14/2025 | 40,780 | $42,003 | 100.00% | 0.05% | |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 38,885 | $40,000 | 100.00% | 0.05% |
| VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 02/10/2025 | 36,992 | $38,102 | 100.00% | 0.04% |
| VELAN CAPITAL INVESTMENT MANAGEMENT LP | 02/14/2025 | 35,000 | $36,050 | 100.00% | 0.04% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 34,054 | $35,074 | -28.53% | 0.04% |
| ALGERT GLOBAL LLC | 02/14/2025 | 33,570 | $35,000 | 100.00% | 0.04% |
| XTX TOPCO LTD | 02/13/2025 | 32,922 | $33,910 | -24.60% | 0.04% |
| US BANCORP \DE\ | 02/05/2025 | 30,792 | $31,716 | -8.88% | 0.04% |
| TRAPHAGEN INVESTMENT ADVISORS LLC | 01/17/2025 | 30,500 | $31,415 | 100.00% | 0.04% |
| 02/07/2025 | 25,000 | $25,750 | 100.00% | 0.03% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CytomX Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 102 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 7.31 M
BVF INC/IL: 5.23 M
VANGUARD GROUP INC: 5.16 M
Prosight Management, LP: 3.91 M
MILLENNIUM MANAGEMENT LLC: 3.22 M
ACADIAN ASSET MANAGEMENT LLC: 3.14 M
54.90% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 50.14 M shares in the last 24 months. This purchase volume represents approximately $29.08 M in transactions.